Cambridge Nutrition Sciences faces legal action by Investing.com.

LONDON – Cambridge Nutritional Sciences Plc (AIM: CNSL), a medical diagnostic specialist, has been subpoenaed by its distribution unit Omega Diagnostics for alleged breach of Health, Safety and Environment (HSE) regulations from 2018. The violations concern the handling of biological agents at a facility operated by Omega Southwest, a former Omega subsidiary. Diagnostics Ltd., which was sold in the same year as the acquired entity.

The company accepted the summons and announced that the first hearing is set for March 18, 2025. Cambridge Nutrition Science is currently consulting with legal advisors to determine the most appropriate response to stakeholders and is committed to providing updates as the situation evolves.

The alleged violations are historic and occurred prior to the exit of Omega Southwest, which has since ceased trading and is not part of Cambridge Nutrition Science’s operations or business model. The company clarified that it had no dealings with Omega Southwest at the time of the breach.

Cambridge Nutrition Sciences, listed on the AIM market London Stock Exchange (LON: ) is known for its focus on personalized health and nutrition through its diagnostic products. As the case involves historical charges, the company has not shown any immediate impact on its current business activities.

This legal development comes as the company navigates an increasingly complex regulatory landscape, with industry observers closely monitoring the outcome of such proceedings. Cambridge Nutrition Science’s press release serves as the source for this report, providing a clear update to the public and investors regarding the legal challenge faced by the company’s subsidiary.

This article was created by AI Support and reviewed by an editor. See our T&C for more information.